A LITTLE over three and a half years ago, a new medication, meprobamate, was widely promoted for use in a variety of maladies. There is no doubt of its efficacy as a muscle relaxant and mild sedative. One of the most important factors that caused it to be widely accepted was its apparent freedom from toxic side effects and addiction.1 It is fortunate that meprobamate is relatively innocuous in comparison to other types of so-called "relaxing" or "tranquilizing" drugs, and as such it has been accepted by a large proportion of the lay population as a harmless panacea for a . . .
No takes yet. Share an insight, caveat, or question.
Mohr et al. (1958) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: